Send feedback

FLT3 p.Asp835His

c.2503G>C · rs121913488 · VCV16273

Pathogenic No assertion criteria
Classification
Pathogenic
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9725 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
acute myeloid leukemia

Computational evidence

Protein change
AlphaMissense0.9725likely pathogenic ✓ concordant with ClinVar · top 8% in FLT3
REVEL0.878moderately pathogenic-leaning
SaProtLLR -7.11tolerated
⇒ AlphaMissense and REVEL call this damaging; SaProt does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 2.3, phastCons 1
Regional constrainto/e 0.90unconstrained · MANE · 96 kb · p 0.00044 · regional, not allelic
Overall
CADD29.4PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Cancer therapy — CIViC

DiseaseTherapiesLevelSignificance
Acute Myeloid LeukemiaPonatinib,QuizartinibDResistance
Acute Myeloid LeukemiaSU5614DResistance
Acute Myeloid LeukemiaQuizartinib,SorafenibBResistance
Acute Myeloid LeukemiaSorafenibBResistance
Acute Myeloid LeukemiaMidostaurin,ChemotherapyASensitivity/Response
Acute Myeloid LeukemiaSunitinibCSensitivity/Response
Acute Myeloid LeukemiaSunitinibCSensitivity/Response
Acute Myeloid LeukemiaSunitinibDSensitivity/Response

Variant & gene context

Gene
FLT3
Protein
p.Asp835His
Coding
c.2503G>C
MANE Select
NM_004119
dbSNP
rs121913488
Type
single nucleotide variant
Location
chr13:28018505 (GRCh38)
Gene constraint
LOEUF 0.468 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 76.19 · 11 PDB
Residue 835
a UniProt-annotated variant site (in acute lymphoblastic leukemia patients and acute myelogenous leukemia patients; somatic mutation; constitutively activated); a UniProt-annotated variant site (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated); the protein kinase domain
Full FLT3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/flt3-p-asp835his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown